Malta - englanti - Medicines Authority

glaxo smithkline uk limited - benzoyl peroxide; clindamycin - gel - benzoyl peroxide 30 mg/g; clindamycin 10 mg/g - anti-acne preparations

Malta - englanti - Medicines Authority

glaxo smithkline uk limited - benzoyl peroxide; clindamycin - gel - benzoyl peroxide 50 mg/g; clindamycin 10 mg/g - anti-acne preparations

Yhdysvallat - englanti - NLM (National Library of Medicine)

johnson & johnson consumer inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 100 mg in 1 g - acne medication for the treatment of acne.

Yhdysvallat - englanti - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin phosphate and benzoyl peroxide gel, 1.2%/5% is indicated for the topical treatment of inflammatory acne vulgaris in patients 12 years and older. clindamycin phosphate and benzoyl peroxide gel has not been demonstrated to have any additional benefit when compared with benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne. clindamycin phosphate and benzoyl peroxide gel is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel. [see adverse reactions (6.2).] clindamycin phosphate and benzoyl peroxide gel is contraindicated in those individuals with a history of regional enteritis, ulcerative colitis, pseudomembranous colitis, or antibiotic-associated colitis [see warnings and precautions (5.1)]. pregnanc

Yhdysvallat - englanti - NLM (National Library of Medicine)

viona pharmaceuticals inc - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - adapalene and benzoyl peroxide topical gel is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. adapalene and benzoyl peroxide topical gel is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in adapalene and benzoyl peroxide topical gel. risk summary available pharmacovigilance data with adapalene and benzoyl peroxide topical gel use in pregnant women are insufficient to establish a drug associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with the combination gel. adapalene gel, 0.3% available data from clinical trials with adapalene gel 0.3% use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of adapalene to pregnant r

Yhdysvallat - englanti - NLM (National Library of Medicine)

nextmune ab - benzoyl peroxide gel, usp....2.5%, precipitated sulfur, usp....2.0% -

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

galderma (uk) ltd - benzoyl peroxide - gel - 5 %w/w - benzoyl peroxide

Australia - englanti - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - benzoyl peroxide, quantity: 50 mg/g - cream - excipient ingredients: purified water; citric acid; propyl hydroxybenzoate; stearic acid; propylene glycol; cetyl alcohol; titanium dioxide; glycerol; colloidal anhydrous silica; sodium citrate dihydrate; methyl hydroxybenzoate; glyceryl monostearate; sodium lauryl sulfate; colour - for the treatment of acne.

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - hydrous benzoyl peroxide; clindamycin phosphate -

Kanada - englanti - Health Canada

sandoz canada incorporated - adapalene; benzoyl peroxide - gel - 0.1%; 2.5% - adapalene 0.1%; benzoyl peroxide 2.5% - keratolytic agents